Published in Vaccine Weekly, September 24th, 2003
Treating younger adults with anti-flu drugs is cost-effective because it cuts lost work time, but until now it was not known if the treatment would be cost-effective for older adults. The study is published in the September 1, 2003, issue of Annals of Internal Medicine.
Using published information and computer models, the researchers compared the outcomes and costs of a variety of strategies for caring for older adults with flu-like illness, including no testing or treatment, testing for flu before treatment with a newer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.